Poor patient health is associated with higher caregiver burden for older adults with advanced cancer.

Abstract:

OBJECTIVES:Family caregiver burden among older adults with advanced cancer remains poorly understood. We sought to (1) identify patient factors associated with caregiver burden and (2) examine how amount of time caregiving modifies these relationships. METHODS:Cross-sectional analysis of baseline data from a cluster-randomized palliative care intervention trial including patients with advanced cancer and their family caregivers, recruited from 17 oncology practices in Pennsylvania. Caregiver burden was measured using Zarit Burden Interview (ZBI-12; range 0-48). Patient factors included functional status (Eastern Cooperative Oncology Group), symptom burden (Edmonton Symptom Assessment Scale), anxiety and depression (Hospital Anxiety and Depression Scale), and quality of life (Functional Assessment of Chronic Illness Therapy - Palliative Care). Using adjusted multivariable regression, we analyzed (1) independent associations between patient factors and caregiver burden and (2) how weekly caregiving hours modified these relationships. RESULTS:Among 441 patient-caregiver dyads, mean patient age was 70 ± 10 and caregiver age was 62 ± 13 years. Most caregivers (59%) were patients' partners. Caregivers reported 44.5 ± 53.5 average hours spent caregiving weekly; mean ZBI-12 scores were 10.3 ± 7.3. Worse patient functional status (β = 4.20, p < 0.01), poorer quality of life (β = -0.07, p < 0.01), more anxiety (β = 0.33, p < 0.01) and depression (β = 0.33, p < 0.01) were associated with higher caregiver burden; caregiving hours did not affect these relationships. CONCLUSIONS:In advanced cancer, poor patient physical and mental health is associated with higher caregiver burden regardless of hours caregiving; future studies should examine interventions tailored to alleviate caregiver burden for this group.

journal_name

J Geriatr Oncol

authors

Semere W,Althouse AD,Rosland AM,White D,Arnold R,Chu E,Smith TJ,Schenker Y

doi

10.1016/j.jgo.2021.01.002

subject

Has Abstract

pub_date

2021-01-18 00:00:00

eissn

1879-4068

issn

1879-4076

pii

S1879-4068(21)00002-3

pub_type

杂志文章
  • Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.

    abstract:OBJECTIVES:Older breast cancer survivors (BCS) consistently report more functional limitations than women without cancer, but whether or not these differences remain when using objective measures of physical functioning and the correlates of these measures is unknown. METHODS:Cross-sectional study comparing older (≥60...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.10.006

    authors: Winters-Stone KM,Medysky ME,Savin MA

    更新日期:2019-03-01 00:00:00

  • Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.

    abstract:OBJECTIVE:In this study, we evaluated the Groningen Frailty Indicator (GFI) and the G8 questionnaire as screening tools for a Comprehensive Geriatric Assessment (CGA) in older patients with cancer. PATIENTS AND METHODS:Eligible patients with various types and stages of cancer were evaluated for frailty before treatmen...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2012.08.001

    authors: Baitar A,Van Fraeyenhove F,Vandebroek A,De Droogh E,Galdermans D,Mebis J,Schrijvers D

    更新日期:2013-01-01 00:00:00

  • Clinical judgment versus geriatric assessment for frailty in older patients with cancer.

    abstract:BACKGROUND:Geriatric assessment (GA) is an appropriate method for identifying frailty in older patients with cancer, but a shorter instrument may be easier to use in clinical practice. Clinical judgment is always available and requires no investments in time or resources. The purpose of this study was to assess correla...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.05.011

    authors: van Walree IC,Scheepers ERM,van den Bos F,van Huis-Tanja LH,Emmelot-Vonk MH,Hamaker ME

    更新日期:2020-09-01 00:00:00

  • Aromatase inhibitors: The unexpected breast cancer treatment.

    abstract:OBJECTIVE:Suboptimal adherence with endocrine treatment for breast cancer is influenced by a number of factors but remains poorly understood. We sought to describe the prior knowledge about and expectations of breast cancer treatments among older women retrospecting on their diagnosis and treatment. METHODS:Thematic a...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.024

    authors: Pieters HC,Green E,Sleven M,Stanton AL

    更新日期:2020-04-01 00:00:00

  • How (and why) to ask the older cancer patient about sexual health and sexual minority status.

    abstract::Sexual health and sexual minority status are often undiscussed during oncology visits. Yet, these topics should be addressed in older cancer patients in order to help mitigate the sexual side effects of cancer treatment and to acknowledge - and, at times, help provide - the social support older patients need during th...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2019.08.003

    authors: Cathcart-Rake E,O'Connor JM,Jacobson A,McGuire L,Jatoi A

    更新日期:2020-05-01 00:00:00

  • Controversial issues in the management of older adults with early breast cancer.

    abstract::It is well recognized that the incidence of breast cancer increases significantly with age. Despite this, older people remain under-represented in many clinical trials and their management relies on extrapolation of data from younger patients. Providing an aggressive intervention can be challenging, particularly in le...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2017.05.004

    authors: Mislang AR,Cheung KL,Hamaker ME,Kunkler I,Markopoulos C,Orecchia R,Brain E,Biganzoli L

    更新日期:2017-11-01 00:00:00

  • Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions.

    abstract:OBJECTIVE:To understand how older persons with multiple chronic conditions (MCC) approach decisions about cancer screening. MATERIALS AND METHODS:We conducted interviews with adults >65 years old with at least two chronic conditions who were taking ≥five medications daily. Patients were first asked how age and multimo...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2014.12.001

    authors: Gross CP,Fried TR,Tinetti ME,Ross JS,Genao I,Hossain S,Wolf E,Lewis CL

    更新日期:2015-03-01 00:00:00

  • Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort.

    abstract:BACKGROUND:Because of comorbidities and polypharmacy, older patients with cancer have a greater risk of iatrogenic events. We aimed to characterize potential drug-drug interactions (PDIs) and the risk of unplanned hospitalization in older patients with cancer treated with antineoplastic agents (ANAs). METHODS:We analy...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.023

    authors: Beinse G,Reitter D,Segaux L,Carvahlo-Verlinde M,Rousseau B,Tournigand C,Cudennec T,Laurent M,Boudou-Rouquette P,Paillaud E,Canouï-Poitrine F,Caillet P,ELCAPA Study Group.

    更新日期:2020-05-01 00:00:00

  • An evaluation of elderly patients (≥70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011.

    abstract:OBJECTIVE:Elderly patients with cancer are under-represented in clinical trials, and there is especially scant data on their participation in early-phase trials. In an effort to provide more data, we reviewed our Phase I experience. METHODS:We conducted a retrospective analysis of 461 patients enrolled in Phase I clin...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2013.08.005

    authors: Rowe J,Patel S,Mazo-Canola M,Parra A,Goros M,Michalek J,Kelly K,Weitman S,Karnad A

    更新日期:2014-01-01 00:00:00

  • Envisioning Arti's 'Cadillac study' to assess aging trajectories in cancer survivors.

    abstract::The "Cadillac Study" was the term Arti Hurria, MD often used to articulate her vision of the optimal study to investigate the effects of cancer and its treatments on aging trajectories. In her opinion, this study needed to be designed for near-term clinical translation and have the ability to discern subpopulations of...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.06.009

    authors: Guida JL,Green PA,Gallicchio L

    更新日期:2020-03-01 00:00:00

  • Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.

    abstract:OBJECTIVE:To assess adjuvant chemotherapy recommendations, administration and disease-specific survival for invasive breast cancer (BC) among patients 75years and older compared with that of younger women. MATERIALS AND METHODS:A cohort of patients with primary breast cancer, aged 65-94, stages I-III from 1990 to 2010...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.12.007

    authors: Kaplan HG,Malmgren JA,Atwood MK

    更新日期:2013-04-01 00:00:00

  • The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.

    abstract:OBJECTIVES:To establish whether clinicopathologic and genomic characteristics may explain the poor prognosis associated with advanced age in ER+/HER2- breast cancer. MATERIALS AND METHODS:The cohort included 271 consecutive post-menopausal patients with ER+/HER2- invasive breast cancer ages 55 years and older. Patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.08.007

    authors: Mills M,Liveringhouse C,Lee F,Nanda RH,Ahmed KA,Washington IR,Thapa R,Fridley BL,Blumencranz P,Extermann M,Loftus L,Balducci L,Diaz R

    更新日期:2020-08-25 00:00:00

  • 21-gene recurrence score testing utilization among older women from different races: A population-based study.

    abstract:OBJECTIVES:The influence of older age at diagnosis in combination with race/ethnicity on utilization and results of the 21-gene recurrence score (RS) assay for breast cancer (BC) patients is not fully understood. Our objectives were to evaluate the utilization of RS among older women with BC, the likelihood of a high-r...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.06.004

    authors: Gulbahce HE,White S,Herget KA,Stoddard G,Camp NJ,Buys SS,Sweeney C

    更新日期:2020-07-07 00:00:00

  • Optimal management of localized rectal cancer in older patients.

    abstract::In advising the optimal management for older patients, health care professionals try to balance the risks from frailty, vulnerability, and comorbidity against the patient's ultimate prognosis, potential functional outcomes and quality of life (QOL). At the same time it is important to involve the patient and incorpora...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.08.001

    authors: Bujko K,Glynne-Jones R,Papamichael D,Rutten HJT

    更新日期:2018-11-01 00:00:00

  • Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies.

    abstract:BACKGROUND:The majority of patients with chronic lymphocytic leukemia (CLL) are older and have multiple comorbidities, including other cancer diagnoses. These patients are routinely excluded from participation in clinical trials. OBJECTIVE:In this phase II study, we determined the activity and toxicity of ofatumumab, ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.04.002

    authors: Vitale C,Falchi L,Ciccone M,Burger J,Pemmaraju N,Borthakur G,Wierda WG,Keating MJ,Ferrajoli A

    更新日期:2020-01-01 00:00:00

  • Management and supportive treatment of frail patients with metastatic pancreatic cancer.

    abstract::Data regarding management of frail patients with pancreatic ductal adenocarcinoma practice is currently very scarce. Randomized clinical trials usually exclude these subgroup of patients and the majority of the publications only consider chronological age and ECOG performance status for their classification. Therefore...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.06.005

    authors: Macarulla T,Carrato A,Díaz R,García A,Laquente B,Sastre J,Álvarez R,Muñoz A,Hidalgo M

    更新日期:2019-05-01 00:00:00

  • The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

    abstract:OBJECTIVES:No tools accurately discriminate between older patients who are fit and those who are frail to tolerate systemic palliative treatment. This study evaluates whether domains of geriatric assessment (GA) are associated with increased risk of chemotherapy intolerance in patients who were considered fit to start ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.05.016

    authors: van der Vlies E,Kurk SA,Roodhart JML,Gerritse FL,Pelgrim TC,Vos JM,Sohne M,Hunting CB,Noordzij PG,van der Velden AMT,Los M

    更新日期:2020-04-01 00:00:00

  • Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.

    abstract:BACKGROUND:Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES:to assess the efficacy and safety of regorafenib at it's approved dose in the older population. PATIENTS AND METHODS:This multicenter single-arm phase ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.001

    authors: Aparicio T,Darut-Jouve A,Khemissa Akouz F,Montérymard C,Artru P,Cany L,Romano O,Valenza B,Le Foll C,Delbaldo C,Falandry C,Norguet Monnereau E,Ben Abdelghani M,Smith D,Rinaldi Y,Père Verge D,Baize N,Maillard E,Dohan A

    更新日期:2020-11-01 00:00:00

  • Treatment of older patients with advanced non-small cell lung cancer: A challenge.

    abstract::With a median age of 70 years at diagnosis, lung cancer is a disease of older persons. As a consequence oncologists are confronted with an increasing older lung cancer population for which treatment decisions are needed. In the past years, the therapeutic landscape of advanced non-small cell lung cancer (NSCLC) has ch...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.09.008

    authors: Decoster L,Schallier D

    更新日期:2019-07-01 00:00:00

  • Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

    abstract:OBJECTIVES:To investigate changes in inflammatory biomarkers during induction therapy for older adults with acute myeloid leukemia (AML) and their associations with geriatric assessment (GA) measures and outcomes. METHODS:This was a single institution ancillary study to a prospective observational study (N = 20 consec...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.03.014

    authors: Loh KP,Tooze JA,Nicklas BJ,Kritchevsky SB,Williamson JD,Ellis LR,Powell BL,Pardee TS,Goyal NG,Klepin HD

    更新日期:2020-04-01 00:00:00

  • Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.

    abstract:BACKGROUND:Screening tools are used in geriatric oncology to determine who should receive a Comprehensive Geriatric Assessment (CGA). However, in this prospective study, we evaluated the association between geriatric screening results, measured with the G8 and Groningen Frailty Indicator (GFI), and severe treatment tox...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2013.12.004

    authors: Baitar A,Van Fraeyenhove F,Vandebroek A,De Droogh E,Galdermans D,Mebis J,Schrijvers D

    更新日期:2014-04-01 00:00:00

  • Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity.

    abstract:OBJECTIVES:Older patients with metastatic renal cell carcinoma (mRCC) were underrepresented in pivotal trials. MATERIALS AND METHODS:Consecutive patients with mRCC treated at Aarhus University Hospital with first line tyrosine kinase inhibitors (TKI), mTOR inhibitors, or checkpoint immunotherapy (CPI) were retrospecti...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.12.008

    authors: Hermansen CK,Donskov F

    更新日期:2020-12-31 00:00:00

  • Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

    abstract:OBJECTIVES:Clinical outcomes in older adults with metastatic renal cell carcinoma (mRCC) are poorly understood, particularly in the era of targeted therapies. We characterize survival and relevant treatment-related variables in a modern series. MATERIALS AND METHODS:From an institutional database including 562 patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.11.001

    authors: Pal SK,Hsu J,Hsu S,Hu J,Bergerot P,Carmichael C,Saikia J,Liu X,Lau C,Twardowski P,Figlin RA,Yuh BF

    更新日期:2013-04-01 00:00:00

  • Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

    abstract:OBJECTIVE:Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort. MATERIALS AND METHODS:Women aged 70 years and older diagnosed w...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.05.004

    authors: Schuil H,Derks M,Liefers GJ,Portielje J,van de Velde C,Syed B,Green A,Ellis I,Cheung KL,Bastiaannet E

    更新日期:2018-11-01 00:00:00

  • Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.

    abstract:OBJECTIVES:The global health status of older patients with cancer influences their clinical course, but little is known regarding the influence of the immune system on the global health of older patients with cancer. The goal of this study was to assess the relationships between patient fitness/frailty status and survi...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2018.03.021

    authors: Speigl L,Grieb A,Janssen N,Hatse S,Brouwers B,Smeets A,Floris G,Bailur JK,Kenis C,Neven P,Wildiers H,Pawelec G,Shipp C

    更新日期:2018-11-01 00:00:00

  • Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly.

    abstract::Studies on cancer survival have revealed disparities not only between the elderly and their younger counterparts, but also among the elderly themselves. The aim of this work was to identify sociodemographic, socioeconomic, clinical, and care-related determinants of survival or mortality in older patients with cancer b...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.007

    authors: Galvin A,Delva F,Helmer C,Rainfray M,Bellera C,Rondeau V,Soubeyran P,Coureau G,Mathoulin-Pélissier S

    更新日期:2018-01-01 00:00:00

  • Using heat maps to assess the multidimensional association of comorbidities with survival in older cancer patients treated with chemotherapy.

    abstract:OBJECTIVE:To date, most comorbidity studies have analyzed either a subgroup of frequent diseases, or used summary instruments such as the Charlson score or the Cumulative Illness Rating Scale-Geriatric (CIRS-G). Yet, comorbidity is a multidimensional construct and impacts function, treatment tolerance, and survival. We...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.005

    authors: Lee JJ,Kim J,Sehovic M,Chen L,Extermann M

    更新日期:2017-09-01 00:00:00

  • Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.

    abstract::Adjuvant chemotherapy improves overall survival (OS) following stereotactic body radiotherapy (SBRT) in patients with early stage non-small cell lung cancer and tumors ≥four cm. Here, we aim to evaluate its role following SBRT in older patients. Patients >70 years diagnosed with clinical stages I-II NSCLC, (N0 disease...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.014

    authors: Grinnell M,Appiah AK,Baine M,Ernani V,Marr A,Zhang C,Zhen W,Buddharaju LNR,Smith LM,Ganti AK

    更新日期:2020-09-01 00:00:00

  • Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.

    abstract:OBJECTIVE:Assess the utility of the G8 screening tool and CGA for older adults with head and neck cancer. METHODS:Patients 65years or older with a primary malignancy of the head and neck region were presented at the multidisciplinary team (MDT) meeting. The Geriatric 8 (G8) questionnaire was administered prior. Clinic...

    journal_title:Journal of geriatric oncology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.jgo.2016.05.006

    authors: Neve M,Jameson MB,Govender S,Hartopeanu C

    更新日期:2016-11-01 00:00:00

  • Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core.

    abstract::Current research efforts focusing on improving outcomes of older adults with cancer lack the appropriate infrastructure to support this growing need. The Cancer and Aging Group R21/33 National Institute of Health (NIH)/National Institute of Aging (NIA) grant aims to support development of geriatric oncology research t...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.019

    authors: Elias R,Loh KP,Targia V,Whitehead M,Canin B,Jatoi A,Loscalzo M,Mohile S

    更新日期:2020-03-01 00:00:00